THOUSAND OAKS, Calif.,
May 16, 2019 /PRNewswire/ -- Amgen
(NASDAQ:AMGN) will present at the RBC Health Care Conference at
8:30 a.m. ET and at the UBS Global
Healthcare Conference at 2 p.m. ET on Tuesday, May 21, 2019, in New York City. Elliott
M. Levy, M.D., senior vice president of Global Development
at Amgen, will present at both conferences. Live audio of the
presentation can be accessed from the Events Calendar on
Amgen's website, www.amgen.com, under Investors. A replay of the
webcast will also be available on Amgen's website for at least 90
days following the event.
About Amgen
Amgen is committed to unlocking the potential of biology for
patients suffering from serious illnesses by discovering,
developing, manufacturing and delivering innovative human
therapeutics. This approach begins by using tools like advanced
human genetics to unravel the complexities of disease and
understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages
its expertise to strive for solutions that improve health outcomes
and dramatically improve people's lives. A biotechnology pioneer
since 1980, Amgen has grown to be one of the world's leading
independent biotechnology companies, has reached millions of
patients around the world and is developing a pipeline of medicines
with breakaway potential.
For more information, visit www.amgen.com and follow us on
www.twitter.com/amgen.
CONTACT: Amgen, Thousand
Oaks
Kristen Davis, 805-447-3008
(media)
Jessica Akopyan, 805-447-0974
(media)
Arvind Sood, 805-447-1060
(investors)
View original content to download
multimedia:http://www.prnewswire.com/news-releases/amgen-to-present-at-the-rbc-healthcare-conference-and-the-ubs-global-healthcare-conference-300851976.html
SOURCE Amgen